Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease.

[1]  Ron D. Hays,et al.  The Concept of Clinically Meaningful Difference in Health-Related Quality-of-Life Research , 2012, PharmacoEconomics.

[2]  A. Holland,et al.  Small changes in six-minute walk distance are important in diffuse parenchymal lung disease. , 2009, Respiratory medicine.

[3]  A. Holland,et al.  The six‐minute walk test: a useful metric for the cardiopulmonary patient , 2009, Internal medicine journal.

[4]  G. Guyatt,et al.  Interpretation of treatment changes in 6-minute walk distance in patients with COPD , 2008, European Respiratory Journal.

[5]  B. Celli,et al.  Validation and comparison of reference equations for the 6-min walk distance test , 2008, European Respiratory Journal.

[6]  Thierry Troosters,et al.  American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. , 2006, American journal of respiratory and critical care medicine.

[7]  S. Studenski,et al.  Meaningful Change and Responsiveness in Common Physical Performance Measures in Older Adults , 2006, Journal of the American Geriatrics Society.

[8]  N. Okudan,et al.  Single Dose of Tiotropium Improves the 6-Minute Walk Distance in Chronic Obstructive Pulmonary Disease , 2006, Lung.

[9]  J. Hankinson,et al.  Interpretative strategies for lung function tests , 2005, European Respiratory Journal.

[10]  G. Guyatt,et al.  Commentary--goodbye M(C)ID! Hello MID, where do you come from? , 2005, Health services research.

[11]  A. Holland,et al.  Does unsupported upper limb exercise training improve symptoms and quality of life for patients with chronic obstructive pulmonary disease? , 2004, Journal of cardiopulmonary rehabilitation.

[12]  B. Celli,et al.  The 6‐min walk distance: change over time and value as a predictor of survival in severe COPD , 2004, European Respiratory Journal.

[13]  Steven Piantadosi,et al.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.

[14]  B. Celli,et al.  Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. , 2002, Chest.

[15]  D. Beaton,et al.  Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. , 2002, Current opinion in rheumatology.

[16]  W M Tierney,et al.  Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. , 1999, Medical care.

[17]  E. Weitzenblum,et al.  Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[18]  M. Marmot,et al.  Is the SF-36 a valid measure of change in population health? Results from the Whitehall II study , 1997, BMJ.

[19]  D A Redelmeier,et al.  Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. , 1997, American journal of respiratory and critical care medicine.

[20]  G H Guyatt,et al.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire. , 1994, Journal of clinical epidemiology.

[21]  R. Tibshirani,et al.  An Introduction to the Bootstrap , 1995 .

[22]  R A Deyo,et al.  Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. , 1991, Controlled clinical trials.

[23]  G. Guyatt,et al.  Measurement of health status. Ascertaining the minimal clinically important difference. , 1989, Controlled clinical trials.

[24]  Lewis E. Kazis,et al.  Effect Sizes for Interpreting Changes in Health Status , 1989, Medical care.

[25]  G. Guyatt,et al.  Measuring change over time: assessing the usefulness of evaluative instruments. , 1987, Journal of chronic diseases.